Company Name or Ticker Symbol
Search for other Categories
Matson, Inc.  (MATX)
Other Ticker:  
Price: $35.3400 $-0.45 -1.257%
Day's High: $35.8 Week Perf: 2.23 %
Day's Low: $ 35.13 30 Day Perf: 5.15 %
Volume (M): 149 52 Wk High: $ 41.96
Volume (M$): $ 5,259 52 Wk Avg: $34.79
Open: $35.70 52 Wk Low: $27.73

 Market Capitalization (Millions $) 1,523
 Shares Outstanding (Millions) 43
 Employees 1,056
 Revenues (TTM) (Millions $) 2,174
 Net Income (TTM) (Millions $) 255
 Cash Flow (TTM) (Millions $) -13
 Capital Exp. (TTM) (Millions $) 359

Matson, Inc.
Matson, Inc., a holding company incorporated in January 2012, in the State of Hawaii, and its subsidiaries, is a leading provider of ocean transportation and logistics services. The Company consists of two segments, Ocean Transportation and Logistics.


Matson's Segments
  Company Estimates  
  Revenue Outlook
Matson does not provide revenue guidance.

Earnings Outlook
Matson, Inc. does not provide earnings estimates.

Geographic Revenue Dispersion

Tesla, Inc.

EPS Fell while Sales More than Doubled

Despite very strong Sales growth of 119.75 % year on year to $7.23 billions in the forth quarter, company faced earnings turn positive at $0.81.

Iqvia Holdings Inc.

Sales and Earnings Unchanged

In the forth quarter Iqvia Holdings Inc eps of $0.34 per share compare to $0.00 a year ago and income per share increased by 16.58 % from $0.29 per share from the previous quarter.

Sales remained unchanged to $2.69 billions from $0.00 millions in the same quarter a year ago and sequentially Sales increased by 3.62 % from $2.59 billions.

Emerald Expositions Events, Inc.

Break-even, Revenues Unchanged

For the forth quarter Emerald Expositions Events, Inc reached break-even at $0.00 per share, compare to results of $0.00 per share a year ago quarter, In the previous quarter company realized $0.28 per share.

Sage Therapeutics, Inc.

Losses Widen but Revenues Unchanged

In the forth quarter Sage Therapeutics, Inc increased losses of $-3.38 per share compare to $-1.97 a year ago and increased losses from $-2.63 per share from the previous quarter.

Sales remained unchanged to $0.27 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.

Recro Pharma, Inc.

Company Fail to Break-even Despite Surge in Sales

Company increased losses at $-1.97 per share in the forth quarter, although it's Sales surged by 30.93 % to $22.41 millions from the same quarter a year ago.

Customers Net Income grew by MATX's customers Net margin grew to
177 % 9.95 %
• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers

You need to upgrade your Flash Player

Major Competitors Stock performance

5 Days Decrease / Increase
DOV        2.51% 
SLB        0.5% 
HAL   -0.89%    
L        4.16% 
NOV   -1.89%    
• View Complete Report


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

RGLD's Profile

Stock Price

RGLD's Financials

Business Description


Charts & Quotes

RGLD's News


RGLD's Competitors

Customers & Markets

Economic Indicators

RGLD's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength


Largest Companies

Management Effectivness


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries





At a Glance








About us


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071